MedPath

Conversational AI Platform for Early Pregnancy Care City-wide Recruitment: A Feasibility Study

Not Applicable
Not yet recruiting
Conditions
Early Pregnancy
Registration Number
NCT07197892
Lead Sponsor
University of Pennsylvania
Brief Summary

This study seeks to determine pregnant patients in the Philadelphia area can be recruited to a conversational AI texting platform. The trial will be considered feasible if recruitment goals are met in proportion to delivery volume at the hospital.

Detailed Description

The investigators developed a conversational AI platform to improve periconception care (CIRCA) to engage individuals in their healthcare decision making, reduce barriers to care, and ultimately reduce widespread inequities in reproductive and maternal health.

CIRCA was developed to enable care from positive pregnancy test onward. After a positive test, patients scan a QR code to onboard via SMS to the program. A positive pregnancy test is confirmed, and an estimated gestational duration is calculated from last menstrual period, if known. If unknown, the patient is directed to schedule a visit at a nearby early pregnancy assessment center where they can receive routine testing and counseling to confirm the pregnancy and its gestational duration. They are then able to receive triage and scheduled educational content.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
2637
Inclusion Criteria
  • Willing and able to provide informed consent
  • Access to a working mobile phone
  • Ability to read English
  • Pregnant with a gestational age less than 12 weeks, 6 days by last menstrual period or by ultrasound, or per patient self-report
Exclusion Criteria

N/A

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Feasibility of citywide recruitment of pregnant patients in Philadelphia.12 months

Proportion of pregnant patients in Philadelphia who sign up to use CIRCA texting platform

Secondary Outcome Measures
NameTimeMethod
Platform engagementBetween platform enrollment up until 12 weeks, 6 days gestation

Percentage of surveys completed by participant

Platform acceptabilityTo be completed at 1 week of use and at final study survey (up to 12 weeks 6 days gestation)

Net promoter score (Range 0-10, with a higher score indicating a better rating)

Birth outcomeFrom platform enrollment up until the event of a live birth or other pregnancy outcome.

Early pregnancy loss, ectopic pregnancy, abortion, severe maternal morbidity, preterm birth

Emergency Department UtilizationFrom platform enrollment until 12 weeks, 6 days gestation.

Emergency Department visits

Trial Locations

Locations (1)

Penn Medicine

🇺🇸

Philadelphia, Pennsylvania, United States

Penn Medicine
🇺🇸Philadelphia, Pennsylvania, United States
Arden McAllister
Contact
267-785-8044
arden.mcallister@pennmedicine.upenn.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.